EBITDA Normalization

Full definition

EBITDA normalization removes non-recurring revenue and expense items — a one-time government grant, a litigation settlement, a physician's above-market compensation draw — and adds back costs that would not recur under new ownership, to produce a normalized EBITDA representing the practice's ongoing earning power. In healthcare M&A, normalization adjustments are particularly complex because of physician owner compensation structures: many owners pay themselves both a market-rate physician salary and an owner distribution, and distinguishing fair market value physician compensation from excess owner return requires benchmarking against MGMA specialty standards. Common adjustments in healthcare acquisitions include above- or below-market physician compensation, personal expenses run through the business, one-time equipment purchases, COVID-era relief payments, and non-recurring expansion costs. EHR-level data validation is essential to normalized EBITDA reliability: encounter-level volume and productivity data either confirms or contradicts the adjusted figure, and buyers who skip this validation regularly discover post-close that the normalization assumptions were incorrect. Healthcare practices typically trade at 6–10× trailing normalized EBITDA, making the accuracy of normalization adjustments directly consequential to acquisition price.